Viking’s Oral Weight-Loss Drug Shows Early Efficacy/Safety Promise

Happy stomach
Viking's obesity candidate demonstrates benign GI safety/tolerability profile • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D